[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE341311T1 - Selbstemulgierende lipidmatrix (selm) - Google Patents

Selbstemulgierende lipidmatrix (selm)

Info

Publication number
ATE341311T1
ATE341311T1 AT01270324T AT01270324T ATE341311T1 AT E341311 T1 ATE341311 T1 AT E341311T1 AT 01270324 T AT01270324 T AT 01270324T AT 01270324 T AT01270324 T AT 01270324T AT E341311 T1 ATE341311 T1 AT E341311T1
Authority
AT
Austria
Prior art keywords
lipidmatrix
selm
emulsifying
self
emulsifying lipidmatrix
Prior art date
Application number
AT01270324T
Other languages
English (en)
Inventor
Martin Kuentz
Dieter Roethlisberger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE341311T1 publication Critical patent/ATE341311T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01270324T 2000-12-14 2001-12-08 Selbstemulgierende lipidmatrix (selm) ATE341311T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00127414 2000-12-14

Publications (1)

Publication Number Publication Date
ATE341311T1 true ATE341311T1 (de) 2006-10-15

Family

ID=8170664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270324T ATE341311T1 (de) 2000-12-14 2001-12-08 Selbstemulgierende lipidmatrix (selm)

Country Status (17)

Country Link
US (1) US6719996B2 (de)
EP (1) EP1349541B1 (de)
JP (1) JP4116436B2 (de)
KR (1) KR100602299B1 (de)
CN (1) CN1263446C (de)
AR (1) AR032783A1 (de)
AT (1) ATE341311T1 (de)
AU (2) AU2002216085B8 (de)
BR (1) BRPI0116121B8 (de)
CA (1) CA2431397C (de)
DE (1) DE60123661T2 (de)
DK (1) DK1349541T3 (de)
ES (1) ES2272408T3 (de)
MX (1) MXPA03005169A (de)
PT (1) PT1349541E (de)
WO (1) WO2002047663A1 (de)
ZA (1) ZA200304263B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
DE602005026669D1 (de) 2004-07-06 2011-04-14 Hoffmann La Roche Herstellungsverfahren für carboxamid-pyridin-derivate als zwischenprodukte bei der synthese von nk-1-rezeptor-antagonisten
EP2281556A1 (de) 2005-02-25 2011-02-09 F. Hoffmann-La Roche AG Tablette mit verbesserter Arzneimittelsubstanzdispersibilität
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
CN106512010A (zh) 2009-11-18 2017-03-22 赫尔辛医疗股份公司 用于治疗中枢介导的恶心及呕吐的组合物及方法
EP2722045B1 (de) 2009-11-18 2016-07-06 Helsinn Healthcare SA Zusammensetzungen zur Behandlung von zentral vermitteltem Unwohlsein und Erbrechen
DK2744497T3 (en) 2011-10-18 2016-08-01 Helsinn Healthcare Sa THERAPEUTIC COMBINATION OF netupitant AND palonosetron
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
EP3262948A4 (de) * 2015-02-26 2018-09-05 The Nisshin OilliO Group, Ltd. Pulverförmige fettzusammensetzung für schokolade
EP3347011A4 (de) 2015-09-11 2019-06-19 Chase Pharmaceuticals Corporation Muscarinkombination und deren verwendung zur bekämpfung von hypocholinergen störungen des zentralen nervensystems
MA51658A (fr) 2017-04-10 2020-12-02 Chase Therapeutics Corp Association comprenant un antagoniste de nk1 et méthode de traitement de synucléinopathies
EP3645120A4 (de) 2017-06-30 2021-03-24 Chase Pharmaceuticals Corporation Nk-1 -antagonist-zusammensetzungen und verfahren zur verwendung in der behandlung von depression
CN109200018A (zh) * 2017-07-04 2019-01-15 南京诺瑞特医药科技有限公司 含有奈妥吡坦的微乳制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
DE60014216T2 (de) * 1999-02-24 2006-03-02 F. Hoffmann-La Roche Ag 4-Phenylpyridinderivate und deren Verwendung als NK-1 Rezeptorantagonisten
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
EP1349541A1 (de) 2003-10-08
CA2431397C (en) 2007-05-01
JP4116436B2 (ja) 2008-07-09
WO2002047663A1 (en) 2002-06-20
MXPA03005169A (es) 2003-09-22
CN1263446C (zh) 2006-07-12
KR20030062423A (ko) 2003-07-25
PT1349541E (pt) 2007-01-31
CN1514720A (zh) 2004-07-21
BR0116121A (pt) 2003-10-14
DE60123661T2 (de) 2007-08-16
EP1349541B1 (de) 2006-10-04
CA2431397A1 (en) 2002-06-20
ZA200304263B (en) 2004-03-26
DE60123661D1 (de) 2006-11-16
US20020114837A1 (en) 2002-08-22
BRPI0116121B8 (pt) 2021-05-25
JP2004517837A (ja) 2004-06-17
AU2002216085B2 (en) 2005-11-03
AU2002216085B8 (en) 2006-03-02
ES2272408T3 (es) 2007-05-01
DK1349541T3 (da) 2007-01-08
AU1608502A (en) 2002-06-24
BRPI0116121B1 (pt) 2015-07-14
US6719996B2 (en) 2004-04-13
AR032783A1 (es) 2003-11-26
KR100602299B1 (ko) 2006-07-14

Similar Documents

Publication Publication Date Title
DK1303496T3 (da) Pyrimidinderivater
DE60129698D1 (de) Thrombinrezeptorantagonisten
DE60139356D1 (de) Wirbelarthrodesevorrichtung
ATE252099T1 (de) Biarylcarboxamide
NO20025566D0 (no) Trombopoietinetterlignere
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
NO20032246L (no) Örebeskyttelsesanordning
ATA2932001A (de) Schneefräse
ATE341311T1 (de) Selbstemulgierende lipidmatrix (selm)
DE60102473D1 (de) Indolochinazolinone
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE60134773D1 (de) Allringen
NO20032291D0 (no) Pyrimidinderivater
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
DE50113112D1 (de) Schaltungsanordnung
AR027931A1 (es) Antitranspirantes
NO20024860D0 (no) Hårpleiesammensetninger
FI20000577A0 (fi) Pyridatsinyylifenyylihydratsoneja
NO20003491D0 (no) BagasjehÕndteringssystem
DE50109335D1 (de) Rohrverleger
DE60123263D1 (de) Geschirrspuelmittelzusammensetzungen
NO20013985L (no) Orto-fenylfenolatkonsentrater
ATA7092001A (de) Skibindungseinstellgerät
AT500246B8 (de) Chokerring
DE50115426D1 (de) Schaltungsanordnung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349541

Country of ref document: EP